JSB Financial Inc. (JFWV)

Regulus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27	23	19	20	28	24
Market Cap Growth	-4.27%	22.30%	-5.38%	-28.79%	16.17%	-7.61%
Last Close Price	105.00	87.15	69.24	66.36	91.07	75.69
PE Ratio	6.59	5.54	6.12	5.08	7.71	8.25
PS Ratio	1.63	1.37	1.30	1.35	2.07	1.99
PB Ratio	0.90	0.76	0.74	0.87	0.84	0.77
P/FCF Ratio	5.00	4.21	4.70	4.29	6.11	6.17
P/OCF Ratio	4.76	4.00	4.45	3.96	5.86	5.62
Debt / Equity Ratio	0.26	0.26	1.85	0.95	-	0.01
Debt / FCF Ratio	1.47	1.47	11.66	4.68	-	0.09
Return on Equity (ROE)	14.93%	14.93%	12.79%	13.93%	11.18%	9.85%
Return on Assets (ROA)	0.79%	0.79%	0.63%	0.87%	0.89%	0.82%
Earnings Yield	15.18%	18.06%	16.34%	19.67%	12.97%	12.12%
FCF Yield	19.99%	23.78%	21.29%	23.31%	16.37%	16.22%
Dividend Yield	2.29%	-	3.39%	3.39%	2.36%	2.58%
Payout Ratio	15.05%	15.05%	20.89%	15.71%	15.90%	18.45%
Buyback Yield / Dilution	7.79%	5.47%	1.22%	0.27%	0.99%	-
Total Shareholder Return	10.08%	5.47%	4.61%	3.66%	3.35%	2.58%

Source: S&P Global Market Intelligence. Banks template. Financial Sources.